Established · publishing since 1996Rising activity
Prostate Cancer Diagnosis and TreatmentHealth Systems, Economic Evaluations, Quality of LifeProstate Cancer Treatment and ResearchUrinary Bladder and Prostate ResearchPelvic floor disorders treatments
Publications
24
Citations
220
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
In context
Among 4,953 established Medicine PIs within our index
Citations: 220p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 2.8p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~25 · 0% small-team papers (≤3 authors) · across 1 venues
Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
Recent publications
- Supplementary Figure 2 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Table 2 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Table 3 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Figure 4 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Figure 1 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Table 1 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Table 5 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Data from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Table 4 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Supplementary Figure 3 from Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
2024
- Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
Cancer Epidemiology Biomarkers & Prevention · 2024
Publishes in
- JAMA×2
- The Journal of Urology×2
- Cancer Epidemiology Biomarkers & Prevention×1
Similar researchers
By research-topic overlap
- Kristian Stensland
Medicine · University of Michigan
- Susan Linsell
Medicine · University of Michigan
- Apoorv Dhir
Medicine · University of Michigan
- John T. Wei
Medicine · University of Michigan
- Michael W. Kattan
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile